国家: 澳大利亚
语言: 英文
来源: Department of Health (Therapeutic Goods Administration)
pamidronate disodium, Quantity: 90 mg
Sandoz Pty Ltd
pamidronate disodium
Injection, concentrated
Excipient Ingredients: mannitol; sodium hydroxide; phosphoric acid; water for injections
Intravenous
1
Medicine Registered
(S4) Prescription Only Medicine
Treatment of conditions associated with increased osteoclast activity: predominantly lytic bone metastases from breast cancer and advanced multiple myeloma; acute management of tumour-induced hypercalcaemia (Hypercalcaemia of malignancy); treatment of symptomatic Paget's disease of bone.
Visual Identification: Clear, colourless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2006-01-23